RGEN — Repligen Corporation stock price, charts and financials

QT47Repligen Corporation

Repligen Corporation (NASDAQ: RGEN) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
149.78
+2.72+1.85%
OverviewShort InterestFilings
RGENQT47Repligen Corporation·NASDAQ
149.78+1.85%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 2026425Prospectus / business-combination communication
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 202610-QQuarterly report
Jul 28, 20268-KCurrent report
Jul 24, 2026425Prospectus / business-combination communication
Jul 22, 20268-KCurrent report
Jul 22, 2026425Prospectus / business-combination communication
Jul 22, 2026425Prospectus / business-combination communication
Jul 17, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 20268-KCurrent report
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 06, 202610-QQuarterly report
May 05, 20268-KCurrent report
Apr 27, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 20264Statement of changes in beneficial ownership
#1 / 25 of 337
Page
▼
/ 14